Clinical Trials Arena October 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
As artificial intelligence (AI) permeates clinical trial operations more than ever, workforces will have to adapt to the changing tides, said experts at the recent Outsourcing in Clinical Trials New England conference.
The event, held from 23–24 October, gathered experts across the clinical trial industry to discuss the evolving landscape of AI in the pharmaceutical sector. “Our industries are terrible at adopting new technology,” says Manny Lazaro, the senior vice president of clinical operations and data management at the neuroscience biotech Cerevel Therapeutics. Lazaro highlighted the falling momentum behind major clinical trends such as decentralised clinical trials and the wave of eCOA...